A carregar...
Epigenetic therapy overcomes treatment resistance in T-cell prolymphocytic leukemia
T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with distinct features and an aggressive clinical course. Early relapse and short overall survival are commonplace. Use of the monoclonal anti-CD52 antibody alemtuzumab has improved the rate of complete remission and duration o...
Na minha lista:
| Publicado no: | Sci Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807901/ https://ncbi.nlm.nih.gov/pubmed/26109102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaa5079 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|